Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials |
Autore | Kazmierski Wieslaw M |
Pubbl/distr/stampa | Hoboken, : Wiley, 2011 |
Descrizione fisica | 1 online resource (470 p.) |
Disciplina | 615/.7924 |
Soggetto topico |
Antiviral Agents -- therapeutic use
Antiviral agents Clinical Trials as Topic Drug Discovery Drug Evaluation Epidemiologic Studies Chemistry, Pharmaceutical Evaluation Studies as Topic Investigative Techniques Anti-Infective Agents Epidemiologic Methods Pharmacology Therapeutic Uses Health Care Evaluation Mechanisms Chemistry Biological Science Disciplines Natural Science Disciplines Quality of Health Care Public Health Pharmacologic Actions Environment and Public Health Health Care Quality, Access, and Evaluation Chemical Actions and Uses Health Care Antiviral Agents Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology |
ISBN |
1-283-20363-4
9786613203632 0-470-92935-9 0-470-92934-0 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
ANTIVIRAL DRUGS; CONTENTS; CONTRIBUTORS; PREFACE; PART I HUMAN IMMUNODEFICIENCY VIRUS; 1 Discovery and Development of Atazanavir; 2 Discovery and Development of PL-100, A Novel HIV-1 Protease Inhibitor; 3 Darunavir (Prezista, TMC114): From Bench to Clinic, Improving Treatment Options for HIV-Infected Patients; 4 Discovery and Development of Tipranavir; 5 TMC278 (Rilpivirine): A Next-Generation NNRTI in Phase III Clinical Development for Treatment-Naive Patients; 6 Etravirine: From TMC125 to Intelence: A Treatment Paradigm Shift for HIV-Infected Patients
7 Discovery and Development of Tenofovir Disoproxil Fumarate8 Discovery and Development of Apricitabine; 9 Discovery and Development of Maraviroc and PF-232798: CCR5 Antagonists for the Treatment of HIV-1 Infection; 10 Discovery of the CCR5 Antagonist Vicriviroc (Sch 417690/Sch-D) for the Treatment of HIV-1 Infection; 11 Discovery and Development of HIV-1 Entry Inhibitors That Target gp120; 12 Discovery of MK-0536: A Potential Second-Generation HIV-1 Integrase Strand Transfer Inhibitor with a High Genetic Barrier to Mutation; 13 Discovery and Development of HIV Integrase Inhibitor Raltegravir 14 Elvitegravir: A Novel Monoketo Acid HIV-1 Integrase Strand Transfer InhibitorPART II HEPATITIS C VIRUS; 15 Discovery and Development of Telaprevir; 16 Discovery and Development of BILN 2061 and Follow-up BI 201335; 17 Intervention of Hepatitis C Replication Through NS3-4A, the Protease Inhibitor Boceprevir; 18 Discovery and Development of the HCV NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227); 19 Discovery and Development of the HCV Protease Inhibitor TMC435; 20 Discovery and Clinical Evaluation of the Nucleoside Analog Balapiravir (R1626) for the Treatment of HCV Infection 21 Discovery and Development of PSI-6130/RG712822 Discovery of Cyclophilin Inhibitor NIM811 as a Novel Therapeutic Agent for HCV; 23 HCV Viral Entry Inhibitors; PART III RESPIRATORY SYNCYTIAL VIRUS INHIBITORS; 24 Discovery of the RSV Inhibitor TMC353121; 25 Discovery and Development of Orally Active RSV Fusion Inhibitors; 26 Discovery and Development of RSV604; PART IV INFLUENZA, HEPATITIS B, AND CYTOMEGALOVIRUS INHIBITORS; 27 Discovery and Development of Influenza Virus Sialidase Inhibitor Relenza; 28 Discovery and Development of Entecavir 29 Benzimidazole Ribonucleosides: Novel Drug Candidates for the Prevention and Treatment of Cytomegalovirus DiseasesINDEX; Color Plate |
Record Nr. | UNINA-9910139613803321 |
Kazmierski Wieslaw M
![]() |
||
Hoboken, : Wiley, 2011 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials |
Autore | Kazmierski Wieslaw M |
Pubbl/distr/stampa | Hoboken, : Wiley, 2011 |
Descrizione fisica | 1 online resource (470 p.) |
Disciplina | 615/.7924 |
Soggetto topico |
Antiviral Agents -- therapeutic use
Antiviral agents Clinical Trials as Topic Drug Discovery Drug Evaluation Epidemiologic Studies Chemistry, Pharmaceutical Evaluation Studies as Topic Investigative Techniques Anti-Infective Agents Epidemiologic Methods Pharmacology Therapeutic Uses Health Care Evaluation Mechanisms Chemistry Biological Science Disciplines Natural Science Disciplines Quality of Health Care Public Health Pharmacologic Actions Environment and Public Health Health Care Quality, Access, and Evaluation Chemical Actions and Uses Health Care Antiviral Agents Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology |
ISBN |
1-283-20363-4
9786613203632 0-470-92935-9 0-470-92934-0 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
ANTIVIRAL DRUGS; CONTENTS; CONTRIBUTORS; PREFACE; PART I HUMAN IMMUNODEFICIENCY VIRUS; 1 Discovery and Development of Atazanavir; 2 Discovery and Development of PL-100, A Novel HIV-1 Protease Inhibitor; 3 Darunavir (Prezista, TMC114): From Bench to Clinic, Improving Treatment Options for HIV-Infected Patients; 4 Discovery and Development of Tipranavir; 5 TMC278 (Rilpivirine): A Next-Generation NNRTI in Phase III Clinical Development for Treatment-Naive Patients; 6 Etravirine: From TMC125 to Intelence: A Treatment Paradigm Shift for HIV-Infected Patients
7 Discovery and Development of Tenofovir Disoproxil Fumarate8 Discovery and Development of Apricitabine; 9 Discovery and Development of Maraviroc and PF-232798: CCR5 Antagonists for the Treatment of HIV-1 Infection; 10 Discovery of the CCR5 Antagonist Vicriviroc (Sch 417690/Sch-D) for the Treatment of HIV-1 Infection; 11 Discovery and Development of HIV-1 Entry Inhibitors That Target gp120; 12 Discovery of MK-0536: A Potential Second-Generation HIV-1 Integrase Strand Transfer Inhibitor with a High Genetic Barrier to Mutation; 13 Discovery and Development of HIV Integrase Inhibitor Raltegravir 14 Elvitegravir: A Novel Monoketo Acid HIV-1 Integrase Strand Transfer InhibitorPART II HEPATITIS C VIRUS; 15 Discovery and Development of Telaprevir; 16 Discovery and Development of BILN 2061 and Follow-up BI 201335; 17 Intervention of Hepatitis C Replication Through NS3-4A, the Protease Inhibitor Boceprevir; 18 Discovery and Development of the HCV NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227); 19 Discovery and Development of the HCV Protease Inhibitor TMC435; 20 Discovery and Clinical Evaluation of the Nucleoside Analog Balapiravir (R1626) for the Treatment of HCV Infection 21 Discovery and Development of PSI-6130/RG712822 Discovery of Cyclophilin Inhibitor NIM811 as a Novel Therapeutic Agent for HCV; 23 HCV Viral Entry Inhibitors; PART III RESPIRATORY SYNCYTIAL VIRUS INHIBITORS; 24 Discovery of the RSV Inhibitor TMC353121; 25 Discovery and Development of Orally Active RSV Fusion Inhibitors; 26 Discovery and Development of RSV604; PART IV INFLUENZA, HEPATITIS B, AND CYTOMEGALOVIRUS INHIBITORS; 27 Discovery and Development of Influenza Virus Sialidase Inhibitor Relenza; 28 Discovery and Development of Entecavir 29 Benzimidazole Ribonucleosides: Novel Drug Candidates for the Prevention and Treatment of Cytomegalovirus DiseasesINDEX; Color Plate |
Record Nr. | UNINA-9910808713803321 |
Kazmierski Wieslaw M
![]() |
||
Hoboken, : Wiley, 2011 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Cardiac resynchronization therapy for congestive heart failure : prepared for agency for healthcare research and quality |
Pubbl/distr/stampa | [Place of publication not identified], : U S Dept of Health and Human Services Agency for Healthcare Research and Quality, 2004 |
Collana |
Evidence report/technology assessment. Summary
AHRQ pub. |
Soggetto topico |
Controlled Clinical Trials as Topic
Clinical Medicine Electric Stimulation Therapy Evidence-Based Practice Heart Diseases Clinical Trials as Topic Cardiovascular Diseases Medicine Therapeutics Health Occupations Evaluation Studies as Topic Epidemiologic Studies Diseases Diagnostic Techniques and Procedures Health Care Evaluation Mechanisms Epidemiologic Methods Investigative Techniques Public Health Quality of Health Care Environment and Public Health Health Care Quality, Access, and Evaluation Health Care Evidence-Based Medicine Randomized Controlled Trials as Topic Cardiac Pacing, Artificial Heart Failure |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910693974603321 |
[Place of publication not identified], : U S Dept of Health and Human Services Agency for Healthcare Research and Quality, 2004 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Criteria for distinguishing effectiveness from efficacy trials in systematic reviews |
Pubbl/distr/stampa | [Place of publication not identified], : Agency for Healthcare Research and Quality, 2006 |
Descrizione fisica | 1 online resource |
Disciplina | 610.72/4 |
Collana |
Technical Reviews
AHRQ publication |
Soggetto topico |
Epidemiologic Studies
Evaluation Studies as Topic Epidemiologic Methods Health Care Evaluation Mechanisms Investigative Techniques Public Health Diagnostic Techniques and Procedures Quality of Health Care Environment and Public Health Health Care Quality, Access, and Evaluation Health Care Clinical Trials as Topic Medicine Health & Biological Sciences Medical Research |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910698279703321 |
[Place of publication not identified], : Agency for Healthcare Research and Quality, 2006 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Management of menopause-related symptoms |
Pubbl/distr/stampa | [Place of publication not identified], : Agency for Healthcare Research and Quality U S Dept of Health and Human Services, 2005 |
Descrizione fisica | 1 online resource |
Disciplina | 362.198/175 |
Collana | Evidence report/technology assessment Management of menopause-related symptoms |
Soggetto topico |
Menopause - Treatment
Evidence-based medicine Clinical Medicine Epidemiologic Studies Investigative Techniques Evidence-Based Practice Pathological Conditions, Signs and Symptoms Hormone Replacement Therapy Climacteric Sexual Development Health Occupations Medicine Drug Therapy Diseases Reproductive Physiological Phenomena Health Care Evaluation Mechanisms Epidemiologic Methods Therapeutics Reproductive Physiological Processes Reproductive and Urinary Physiological Phenomena Quality of Health Care Public Health Environment and Public Health Health Care Quality, Access, and Evaluation Health Care Cohort Studies Cross-Sectional Studies Estrogen Replacement Therapy Methods Menopause Signs and Symptoms Evidence-Based Medicine Health & Biological Sciences Gynecology & Obstetrics |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910693974403321 |
[Place of publication not identified], : Agency for Healthcare Research and Quality U S Dept of Health and Human Services, 2005 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Prevention of urinary and fecal incontinence in adults |
Pubbl/distr/stampa | [Place of publication not identified], : U S Dept of Health and Human Services Public Health Service Agency for Healthcare Research and Q, 2007 |
Descrizione fisica | 1 online resource |
Collana | Evidence report/technology assessment Prevention of urinary and fecal incontinence in adults |
Soggetto topico |
Urinary incontinence - Prevention
Fecal incontinence - Prevention Evidence-based medicine Risk Epidemiologic Studies Evidence-Based Practice Rectal Diseases Causality Clinical Medicine Urination Disorders Urological Manifestations Epidemiologic Methods Urologic Diseases Health Occupations Health Care Evaluation Mechanisms Probability Epidemiologic Factors Intestinal Diseases Medicine Signs and Symptoms Statistics as Topic Quality of Health Care Male Urogenital Diseases Pathological Conditions, Signs and Symptoms Female Urogenital Diseases Gastrointestinal Diseases Public Health Investigative Techniques Environment and Public Health Health Care Quality, Access, and Evaluation Digestive System Diseases Female Urogenital Diseases and Pregnancy Complications Diagnostic Techniques and Procedures Diseases Health Care Fecal Incontinence Evidence-Based Medicine Risk Factors Urinary Incontinence Health & Biological Sciences Urology & Nephrology |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910698356103321 |
[Place of publication not identified], : U S Dept of Health and Human Services Public Health Service Agency for Healthcare Research and Q, 2007 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Update on acute bacterial rhinosinusitis |
Pubbl/distr/stampa | [Place of publication not identified], : Agency for Healthcare Research and Quality, 2005 |
Descrizione fisica | 1 online resource |
Disciplina | 616.2/12 |
Collana |
Evidence Reports/Technology Assessments
AHRQ publication |
Soggetto topico |
Controlled Clinical Trials as Topic
Respiratory Tract Infections Bacterial Infections and Mycoses Disease Attributes Paranasal Sinus Diseases Diseases Clinical Trials as Topic Nose Diseases Respiratory Tract Diseases Pathologic Processes Epidemiologic Studies Otorhinolaryngologic Diseases Evaluation Studies as Topic Pathological Conditions, Signs and Symptoms Epidemiologic Methods Investigative Techniques Health Care Evaluation Mechanisms Quality of Health Care Diagnostic Techniques and Procedures Public Health Health Care Quality, Access, and Evaluation Environment and Public Health Health Care Randomized Controlled Trials as Topic Bacterial Infections Sinusitis Acute Disease Medicine Health & Biological Sciences Otorhinolaryngology |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910693953603321 |
[Place of publication not identified], : Agency for Healthcare Research and Quality, 2005 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|